The above article supports the value of low-level infrared light stimulation using sophisticated blood oxygenation and imaging technology. We used similar though less advanced tools in our 2012 study 28 days of 6-minute, transcranial and intraocular 1065-1075nm photobiomodulation of subjects struggling with probable Alzheimer's disease. The current study using the same device is now 56-days with more powerful lLED stimulation.
Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general.
Monday & Thursday: 11am - 6pm
remote conferencing available
Main Office- PA
8120 Old York Road,
Elkins Park, PA 19027
New York Office
1619 3rd Ave. Suite 202 New York, NY 10128
QuietMIND Foundation is a 501c3 charitable nonprofit. Donations are fully tax deductible. We work to provide services regardless of ability to pay, please help those who need our help.